Transcat (NASDAQ:TRNS) Releases Earnings Results, Beats Expectations By $0.05 EPS

Transcat (NASDAQ:TRNS) posted its earnings results on Tuesday. The scientific and technical instruments company reported $0.56 earnings per share for the quarter, topping analysts’ consensus estimates of $0.51 by $0.05, Zacks reports. The company had revenue of $89.33 million during the quarter, compared to analyst estimates of $89.79 million. Transcat had a net margin of 1.62% and a return on equity of 5.87%.

Here are the key takeaways from Transcat’s conference call:

• Transcat reported a strong fiscal fourth quarter, with consolidated revenue up 16% to $89.3 million and adjusted EBITDA up 16%, while full-year revenue rose 19% and adjusted EBITDA increased 23%.
• Service revenue continued to be the main growth engine, rising 18% in Q4 with 7% organic growth, marking the 68th consecutive quarter of year-over-year service revenue growth.
• Management said the company gained market share in calibration services during fiscal 2026 and expects sequentially higher service organic growth in Q1, with a path to high single-digit organic growth for the full year.
• Gross margins improved across the business, with consolidated gross margin up 50 basis points in Q4 and service margins expected to improve year over year in fiscal 2027 as new customer onboarding normalizes.
• Transcat emphasized an active M&A pipeline and highlighted the SCM Metrology acquisition as its first operating presence in Latin America, while also pointing to growth opportunities in key U.S. geographies and its expanding rental business.

Transcat Stock Performance

Shares of TRNS opened at $80.32 on Thursday. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.21 and a quick ratio of 1.85. Transcat has a one year low of $50.23 and a one year high of $93.20. The company has a 50-day simple moving average of $75.87 and a two-hundred day simple moving average of $68.11. The firm has a market capitalization of $749.39 million, a PE ratio of 138.49 and a beta of 0.68.

Institutional Trading of Transcat

Several institutional investors and hedge funds have recently bought and sold shares of TRNS. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Transcat by 6.3% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 5,462 shares of the scientific and technical instruments company’s stock worth $407,000 after buying an additional 325 shares during the period. Jane Street Group LLC purchased a new stake in Transcat in the first quarter worth about $1,674,000. JPMorgan Chase & Co. lifted its holdings in Transcat by 88.3% in the second quarter. JPMorgan Chase & Co. now owns 8,555 shares of the scientific and technical instruments company’s stock worth $735,000 after buying an additional 4,012 shares during the period. Legal & General Group Plc lifted its holdings in Transcat by 6.1% in the second quarter. Legal & General Group Plc now owns 9,551 shares of the scientific and technical instruments company’s stock worth $821,000 after buying an additional 548 shares during the period. Finally, Rhumbline Advisers lifted its holdings in Transcat by 23.3% in the second quarter. Rhumbline Advisers now owns 16,171 shares of the scientific and technical instruments company’s stock worth $1,390,000 after buying an additional 3,061 shares during the period. 98.34% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the stock. Zacks Research upgraded shares of Transcat from a “strong sell” rating to a “hold” rating in a report on Friday, May 15th. Weiss Ratings reiterated a “sell (d)” rating on shares of Transcat in a report on Monday, May 4th. One analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Transcat has an average rating of “Moderate Buy” and a consensus target price of $105.33.

About Transcat

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.